The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Obesity, dyslipidemia, and diabetes as determinants of response to immune checkpoint inhibitors in non-small cell lung cancer.
 
Soravis Alm Osataphan
No Relationships to Disclose
 
Muhammad Awidi
No Relationships to Disclose
 
Yu Jen Jan
No Relationships to Disclose
 
Shriram Sundararaman
Honoraria - LEK
Patents, Royalties, Other Intellectual Property - Use of Heparin to Promote Type I Interferon Signaling (WO2021041532)
 
Hollis Viray
No Relationships to Disclose
 
Edward Frankenberger
No Relationships to Disclose
 
Melissa Mariano
No Relationships to Disclose
 
Katherine Ann Stafford
Patents, Royalties, Other Intellectual Property - Parent with patents on VKOR gene. (I)
 
Aleksandra Kolnick
No Relationships to Disclose
 
Hind Ghazalah
No Relationships to Disclose
 
Mary-Elizabeth Patti
Consulting or Advisory Role - AstraZeneca/MedImmune; Eiger BioPharmaceuticals; Fractyl; Hanmi; MBX Biosciences; MBX Biosciences; Poxel
Research Funding - Dexcom
 
Krishna Soujanya Gunturu
No Relationships to Disclose
 
Deepa Rangachari
Honoraria - AstraZeneca
Consulting or Advisory Role - Advance Medical; DynaMed; Teladoc
Research Funding - Abbvie/Stemcentrx (Inst); Bristol-Myers Squibb (Inst); Novocure (Inst)
 
Daniel Botelho Costa
Honoraria - Pfizer; Takeda/Millennium
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Janssen Oncology; Takeda/Millennium; Teladoc
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Genentech (Inst); Merck (Inst); Merrimack (Inst); Pfizer (Inst); Spectrum Pharmaceuticals (Inst); Takeda/Millennium (Inst)
 
Prudence B. Lam
Honoraria - Myriad Genetics
Speakers' Bureau - Myriad Genetics